HLA-G and MIC expression in tumors and their role in anti-tumor immunity
- 1 February 2003
- journal article
- review article
- Published by Elsevier in Trends in Immunology
- Vol. 24 (2) , 82-87
- https://doi.org/10.1016/s1471-4906(02)00039-x
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- MICA triggering signal for NK cell tumor lysis is counteracted by HLA‐G1‐mediated inhibitory signalInternational Journal of Cancer, 2002
- HLA-G in Melanoma: A New Strategy to Escape from Immunosurveillance?Oncology Research and Treatment, 2002
- Expression of Stress-induced MHC Class I Related Chain Molecules on Human MelanomaJournal of Investigative Dermatology, 2002
- MICA Gene Polymorphism is Not Associated With an Increased Risk for Skin CancerJournal of Investigative Dermatology, 2002
- Human Leukocyte Antigen G Up-Regulation in Lung Cancer Associates with High-Grade Histology, Human Leukocyte Antigen Class I Loss and Interleukin-10 ProductionThe American Journal of Pathology, 2001
- Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-? immunotherapyCancer, 2001
- MICA and MICB genes: can the enigma of their polymorphism be resolved?Trends in Immunology, 2001
- HLA-G Expression by TumorsAmerican Journal of Reproductive Immunology, 2001
- Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanomaThe Lancet, 2000
- DISTRIBUTION OF HLA‐G ALTERNATIVE mRNAs INCLUDING SOLUBLE FORMS IN NORMAL LYMPHOCYTES AND IN LYMPHOID CELL‐DERIVED LEUKEMIAInternational Journal of Immunogenetics, 1996